Medical Letter on the CDC & FDA

New data from Creighton University illuminate research in human papillomavirus vaccines

Medical Letter on the CDC & FDA Library Library Home This article was published in Medical Letter on the CDC & FDA, which you can subscribe to online.

"The most vocal complaints maintain that its use will promote promiscuity among teenagers, and condemn proposed mandated use for school entry. Some also question evidence for the vaccine's safety. There have been concerns raised by both providers and patients regarding financial barriers to access. Still others argue that additional populations could benefit who have not been included in current recommendations. Clarification of. these issues is essential to advance optimal use of this important new vaccine. There is strong evidence to support HPV vaccine as an effective, safe, and efficient public health measure. School mandates are valuable tools to reduce disparities in availablilty of immunizations," wrote L.K. Ohri and colleagues, Creighton University.

The researchers concluded: "The time has come to consider universal funding as a means to improve access to all recommended vaccines."

Ohri and colleagues published their study in Annals of Pharmacotherapy (HPV vaccine: Immersed in controversy. Annals of Pharmacotherapy, 2007;41(11):1899-1902).

For additional information, contact L.K. Ohri, Creighton University, School Pharmacy & hlth Profess, HLSB Rm 154, 2500 California Pl, Omaha, NE 68178, USA.

The publisher's contact information for the journal Annals of Pharmacotherapy is: Harvey Whitney Books Co., PO Box 42696, Cincinnati, OH 45242, USA.

Keywords: United States, Omaha, Biotechnology, Cancer Vaccines, Cervical Cancer, Cervical Carcinoma, HPV Vaccines, Human Papillomavirus Vaccines, Immunization, Merck & Company Inc., Oncology, Pharmaceutical Business, Pharmaceutical Company, Pharmaceuticals, Pharmacotherapy, Regulatory Actions, Vaccination, Women's Health, Creighton University.

This article was prepared by Medical Letter on the CDC & FDA editors from staff and other reports. Copyright 2008, Medical Letter on the CDC & FDA via NewsRx.com.